DCLRE1C Gene

Last updated on: 13.03.2022

Dieser Artikel auf Deutsch

Synonym(s)

DNA-Dependent Protein Kinase Catalytic Subunit; DNAPK; DNAPKc; DNA-PKC; DNA-PKcs; DNPK1; EC 2.7.11.1; Hyper-Radiosensitivity Of Murine Scid Mutation, Complementing; HYRC; HYRC1; IMD26; P350; P460; Protein Kinase, DNA-Activated, Catalytic Polypeptide, DNA-PK Catalytic Subunit; Protein Kinase, DNA-Activated, Catalytic Subunit; XRCC7

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The DCLRE1C gene (DCLRE1C stands for "DNA Cross-Link Repair 1C") is a protein-coding gene located on chromosome 10p13. The gene encodes a nuclear protein, a nuclease involved in V(D)J recombination. It is required for the repair of double-strand breaks.

The enzyme has single-strand-specific 5'-3' exonuclease activity; it also shows endonuclease activity at 5' and 3' overhangs and hairpins. Furthermore, it plays a role in cell cycle regulation in response to DNA damage.

Mutations in this gene can cause severe combined Athabascan-type immunodeficiency (Athabascan-type disease is more common in individuals of Apache and Navajo descent) and Omenn syndrome (Volk T et al. 2015). Patients with these diseases suffer from frequent infections, diarrhea, and failure to thrive in infancy. Other clinical features include impaired immunity, decreased numbers of polyclonal T and B cells, and sensitivity to ionizing radiation. Without successful bone marrow transplantation, affected individuals usually die within the first 6 months of life.

LiteratureThis section has been translated automatically.

  1. Mou W et al (2021) Compound heterozygous DCLRE1C mutations lead to clinically typical Severe Combined Immunodeficiency presenting with Graft Versus Host Disease. Immunogenetics 73:425-434.
  2. Volk T et al. (2015) DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency. Hum Mol Genet 24:7361-7372.

Last updated on: 13.03.2022